Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Howard Lapsley

Partner, Health & Life Sciences, Oliver Wyman

Market dynamics are ripe for M&A activity. But before being enticed by a mirage, leaders must revisit old lessons.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

An overview of mix shift modeling, including varying recovery scenarios, margin impact, and possible future legislation.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

Part 3: One Size Does Not Fit All

A closer look at unemployment, member migration, and financial impact amidst an ever-changing pandemic.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

Part 2: Healthcare’s ‘Corona Effect’

Ten expectations regarding voluntary offerings, telemedicine, direct contracting, and more as COVID-19 unfolds.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Part 1: Effects of Unemployment

The US Department of Labor cited a record-breaking 6.6 million unemployment claims filed last week. What's next?

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Oral health can be the key driver of patients' ER bills. Proper care for the body’s “gateway” is a compelling value proposition for consumers and the healthcare ecosystem.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Fourteen percent of physicians offer virtual visits. But a new CMS rule may make telehealth more commonplace.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

When it comes to health benefits, paying more doesn't always get you more. But, consumers will open up their wallets for better value.

Partner, Health & Life Sciences, Oliver Wyman

From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Chief Strategy Officer, BCBS of Massachusetts
Partner, Health & Life Sciences, Oliver Wyman

Digital distribution industry leaders face a tipping point. Here's how to stay ahead of healthcare’s ongoing disruption.

Chief Product Officer and Co-Founder, Maxwell Health
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe